Clinical Efficacy, Safety and Tolerability of Collagenase Clostridium Histolyticum for the Treatment of Peyronie Disease in 2 Large Double-Blind, Randomized, Placebo Controlled Phase 3 Studies
Volume: 190, Issue: 1, Pages: 199 - 207
Published: Jul 1, 2013
Abstract
No AccessJournal of UrologyAdult Urology1 Jul 2013Clinical Efficacy, Safety and Tolerability of Collagenase Clostridium Histolyticum for the Treatment of Peyronie Disease in 2 Large Double-Blind, Randomized, Placebo Controlled Phase 3 Studies Martin Gelbard, Irwin Goldstein, Wayne J.G. Hellstrom, Chris G. McMahon, Ted Smith, James Tursi, Nigel Jones, Gregory J. Kaufman, and Culley C. Carson Martin GelbardMartin Gelbard Urology Associates Medical...
Paper Details
Title
Clinical Efficacy, Safety and Tolerability of Collagenase Clostridium Histolyticum for the Treatment of Peyronie Disease in 2 Large Double-Blind, Randomized, Placebo Controlled Phase 3 Studies
Published Date
Jul 1, 2013
Volume
190
Issue
1
Pages
199 - 207
Citation AnalysisPro
You’ll need to upgrade your plan to Pro
Looking to understand the true influence of a researcher’s work across journals & affiliations?
- Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
- Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.
Notes
History